Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.70 |
| ▸ | CA1 | P00915 | 4/20 | 0.70 |
| ▸ | CA2 | P00918 | 4/20 | 0.70 |
| ▸ | CA7 | P43166 | 4/20 | 0.70 |
| ▸ | CA9 | Q16790 | 4/20 | 0.70 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.70 |
| ▸ | CA4 | P22748 | 3/20 | 0.70 |
| ▸ | CA6 | P23280 | 3/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.70 |
| ▸ | CA3 | P07451 | 2/20 | 0.70 |
| ▸ | CA5A | P35218 | 2/20 | 0.70 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.70 |
| ▸ | FUT7 | Q11130 | 2/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.70 |
| ▸ | TP53 | P04637 | 1/20 | 0.70 |
| ▸ | SELL | P14151 | 1/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL348297 | 0.88 | CA1 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27690857 | 0.86 | CA1 (0.54) | CA12CA1CA2CA7CA9 | |
| SCHEMBL28766413 | 0.86 | CA1 (0.54) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27998994 | 0.84 | CA1 (0.52) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL27648549 | 0.83 | CA12 (0.90) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL2726519 | 0.83 | CA12 (0.90) | CA12CA1CA2CA7CA9 | |
| SCHEMBL13895617 | 0.83 | POLB (0.57) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL4918056 | 0.83 | CA12 (1.00) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL1845406 | 0.83 | CA12 (1.00) | CA12CA1CA2CA7CA9 | |
| Gallic Acid SCHEMBL678990 | 0.83 | CA12 (1.00) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240016735-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-01-18 | — | — | US | disclosed |
| WO-2023196370-A1 | LIPID NANOPARTICLES AND LIPOSOMES | YEH, TENG-KUANG (US) | 2023-10-12 | — | — | WO | disclosed |
| US-11744820-B2 | Inhibitors of microbially induced amyloid | AXIAL THERAPEUTICS, INC. (US) | 2023-09-05 | — | — | US | disclosed |
| US-11717549-B2 | Steviol glycoside solubility enhancers | CARGILL, INCORPORATED (US) | 2023-08-08 | — | — | US | disclosed |
| US-9833425-B2 | Gentisic acid is used to improve systemic hemodynamics, hepatic mitochondrial function and lactate acidemia in patients with septic shock | UNIVERSITY OF MANITOBA (CA) | 2017-12-05 | — | — | US | disclosed |
| US-9447028-B2 | Therapeutic aryl-amido-aryl compounds and their use | KING'S COLLEGE LONDON (GB) | 2016-09-20 | — | — | US | disclosed |
| US-20160039747-A1 | Therapeutic Aryl-Amido-Aryl Compounds and Their Use | KING'S COLLEGE LONDON (GB) | 2016-02-11 | — | — | US | disclosed |
| US-20150336981-A1 | MODIFIED POLYPHENOLS AND MODIFIED POLYPHENOL COMPOSITIONS | CELLAROUGE PTY LTD (AU) | 2015-11-26 | — | — | US | disclosed |
| US-9079989-B2 | Charge control resin and manufacturing method of the same | ORIENT CHEMICAL INDUSTRIES CO., LTD. (JP) | 2015-07-14 | — | — | US | disclosed |
| US-20150119348-A1 | CDK5 Inhibitors and Therapeutic Uses Thereof | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2015-04-30 | — | — | US | disclosed |
| WO-2012144754-A2 | COMPOSITION CONTAINING A GALLA RHOIS EXTRACT HAVING VIRUS INHIBITORY EFFECTS OR A COMPOUND ISOLATED THEREFROM AS AN ACTIVE INGREDIENT, AND USES THEREOF | 원광대학교 산학협력단 (KR) | 2012-10-26 | — | — | WO | disclosed |
| US-20120149737-A1 | Therapeutic Aryl-Amido-Aryl Compounds and Their Use | KING'S COLLEGE LONDON (GB) | 2012-06-14 | — | — | US | disclosed |
| US-20120037178-A1 | MORDANT AND HAIR COLORING PRODUCTS CONTAINING THE SAME | NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD. (CN) | 2012-02-16 | — | — | US | disclosed |
| WO-2010082845-A1 | HONEY ANALYSIS | COMVITA NEW ZEALAND LIMITED (NZ) | 2010-07-22 | — | — | WO | disclosed |
| US-7696195-B2 | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-04-13 | — | — | US | disclosed |
| US-20100034762-A1 | Novel enrichment methods for gallic acid esters including 1-O-galloy1-bata-D-glucose and mucic acid gallates medicaments, therapeutic applications and methods of treatment thereof | MAJEED MUHAMMED | 2010-02-11 | — | — | US | disclosed |
| US-7595074-B2 | Polymeric antioxidants | UNIVERSITY OF MASSACHUSETTS LOWELL (US) | 2009-09-29 | — | — | US | disclosed |
| EP-1740577-A2 | SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-01-10 | — | — | EP | disclosed |
| US-20050256099-A1 | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-17 | — | — | US | disclosed |
| WO-2005103037-A2 | SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149737-A1 | Therapeutic Aryl-Amido-Aryl Compounds and Their Use | RARA, RARB, RARG | CA12 4325/4885CA1 1797/4885CA2 4265/4885 |
| US-20240016735-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | SLCO4C1, SLC47A1, ABCB11 | CA12 1909/4885CA1 3656/4885CA2 2319/4885 |
| US-20100034762-A1 | Novel enrichment methods for gallic acid esters including 1-O-galloy1-bata-D-glucose and mucic acid gallates medicaments, therapeutic applications and methods of treatment thereof | GALE, LGALS1, SLC5A1 | CA12 992/4885CA1 1415/4885CA2 1792/4885 |
| US-11744820-B2 | Inhibitors of microbially induced amyloid | APP, PSEN1, BACE1 | CA12 3163/4885CA1 448/4885CA2 1223/4885 |
| US-20120037178-A1 | MORDANT AND HAIR COLORING PRODUCTS CONTAINING THE SAME | TST, TYR, CAT | CA12 1261/4885CA1 1450/4885CA2 1193/4885 |
| US-20150336981-A1 | MODIFIED POLYPHENOLS AND MODIFIED POLYPHENOL COMPOSITIONS | PGC, COMT, EGLN2 | CA12 4275/4885CA1 4510/4885CA2 3925/4885 |
| US-11717549-B2 | Steviol glycoside solubility enhancers | SI, TAS2R7, TAS2R31 | CA12 1617/4885CA1 4077/4885CA2 2372/4885 |
| US-20050256099-A1 | Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions | CALCRL, CALCR, CALCA | CA12 3064/4885CA1 1869/4885CA2 814/4885 |
| US-20150119348-A1 | CDK5 Inhibitors and Therapeutic Uses Thereof | CDK5, CDK3, CDKL1 | CA12 4595/4885CA1 3587/4885CA2 3583/4885 |
| US-20160039747-A1 | Therapeutic Aryl-Amido-Aryl Compounds and Their Use | RARA, RARB, RARG | CA12 4325/4885CA1 1797/4885CA2 4265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.